Neuroprotection by resveratrol in diabetic neuropathy: Concepts & mechanisms

Current Medicinal Chemistry

Volumn 20, Issue 36, 2013, Pages 4640-4645

  Kumar, A ^a   Negi, G ^a   Sharma, S S ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Diabetic neuropathy; Neuroprotection; NF B; Nrf2; Resveratrol; SIRT

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; NITRIC OXIDE; RESVERATROL; SIRTUIN 1; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIABETIC NEUROPATHY; DRUG BIOAVAILABILITY; HYPERALGESIA; MOUSE; NERVE CONDUCTION; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL NEUROPATHY; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIABETIC NEUROPATHIES; HUMANS; NEUROPROTECTIVE AGENTS; STILBENES;

EID: 84887937515     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/09298673113209990151     Document Type: Article

References (62)

1. Edwards, J.L.; Vincent, A.M.; Cheng, H.T.; Feldman, E.L. Diabetic neuropathy: mechanisms to management. Pharmacol. Ther., 2008, 120(1), 1-34.
2. Obrosova, I.G.; Drel, V.R.; Oltman, C.L.; Mashtalir, N.; Tibrewala, J.; Groves, J.T.; Yorek, M.A. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats. Am. J. Physiol. Endocrinol. Metab., 2007, 293(6), E1645-E1655.
3. Vincent, A.M.; Russell, J.W.; Low, P.; Feldman, E.L. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr. Rev., 2004, 25(4), 612-628.
4. Little, A.A.; Edwards, J.L.; Feldman, E.L. Diabetic neuropathies. Pract. Neurol., 2007, 7(2), 82-92.
5. Wang, Y.; Schmeichel, A.M.; Iida, H.; Schmelzer, J.D.; Low, P.A. Enhanced inflammatory response via activation of NF-kappaB in acute experimental diabetic neuropathy subjected to ischemiareperfusion injury. J. Neurol. Sci., 2006, 247(1), 47-52.
6. Negi, G.; Kumar, A.; Joshi, R.P.; Ruby, P.K.; Sharma, S.S. Oxidative stress and diabetic neuropathy: current status of antioxidants IIOAB. J., 2011, 2(6), 71-78.
7. Negi, G.; Kumar, A.; Joshi, R.P.; Sharma, S.S. Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle. Biochem. Biophys. Res. Commun., 2011, 408(1), 1-5.
8. Malik, R.A.; Masson, E.A.; Sharma, A.K.; Lye, R.H.; Ah-See, A.K.; Compton, A.M.; Tomlinson, D.R.; Hanley, S.P.; Boulton, A.J. Hypoxic neuropathy: relevance to human diabetic neuropathy. Diabetologia, 1990, 33(5), 311-318.
9. Stevens, M.J.; Obrosova, I.; Cao, X.; Van Huysen, C.; Greene, D.A. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes, 2000, 49(6), 1006-1015.
10. Kuhad, A.; Chopra, K. Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy. Neuropharmacology, 2009, 57(4), 456-462.
11. Sayyed, S.G.; Kumar, A.; Sharma, S.S. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy. Life Sci., 2006, 79(8), 777-783.
12. Sharma, S.; Kulkarni, S.K.; Chopra, K. Resveratrol, a polyphenolic phytoalexin attenuates thermal hyperalgesia and cold allodynia in STZinduced diabetic rats. Indian. J. Exp. Biol., 2006, 44(7), 566-569.
13. Sharma, S.; Kulkarni, S.K.; Chopra, K. Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Fundam. Clin. Pharmacol., 2007, 21(1), 89-94.
14. Vincent, A.M.; Edwards, J.L.; Sadidi, M.; Feldman, E.L. The antioxidant response as a drug target in diabetic neuropathy. Curr. Drug Targets, 2008, 9(1), 94-100.
15. Vincent, A.M.; Feldman, E.L. New insights into the mechanisms of diabetic neuropathy. Rev. Endocr. Metab. Disord., 2004, 5(3), 227-236.
16. Olas, B.; Nowak, P.; Wachowicz, B. Resveratrol protects against peroxynitrite-induced thiol oxidation in blood platelets. Cell Mol. Biol. Lett., 2004, 9(4A), 577-587.
17. Olas, B.; Wachowicz, B. Biological activity of resveratrol. Postepy Hig. Med. Dosw., 2001, 55(1), 71-79.
18. Catalgol, B.; Batirel, S.; Taga, Y.; Ozer, N.K. Resveratrol: French paradox revisited. Front Pharmacol., 2012, 3, 141.
19. Li, H.; Xia, N.; Forstermann, U. Cardiovascular effects and molecular targets of resveratrol. Nitric Oxide, 2012, 26(2), 102-110.
20. Chiva-Blanch, G.; Urpi-Sarda, M.; Ros, E.; Valderas-Martinez, P.; Casas, R.; Arranz, S.; Guillen, M.; Lamuela-Raventos, R.M.; Llorach, R.; Andres-Lacueva, C.; Estruch, R. Effects of red wine polyphenols and alcohol on glucose metabolism and the lipid profile: a randomized clinical trial. Clin. Nutr., 2012, 32(2), 200-206.
21. Kraft, A.D.; Johnson, D.A.; Johnson, J.A. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tertbutylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J. Neurosci., 2004, 24(5), 1101-1112.
22. Zhuang, H.; Kim, Y.S.; Koehler, R.C.; Dore, S. Potential mechanism by which resveratrol, a red wine constituent, protects neurons. Ann. N. Y. Acad. Sci., 2003, 993, 276-286; discussion 287-278.
23. Sakata, Y.; Zhuang, H.; Kwansa, H.; Koehler, R.C.; Dore, S. Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp. Neurol., 2010, 224(1), 325-329.
24. Kumar, A.; Sharma, S.S. NF-kappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy. Biochem. Biophys. Res. Commun., 2010, 394(2), 360-365.
25. Manna, S.K.; Mukhopadhyay, A.; Aggarwal, B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol., 2000, 164(12), 6509-6519.
26. Olholm, J.; Paulsen, S.K.; Cullberg, K.B.; Richelsen, B.; Pedersen, S.B. Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants. Int. J. Obes. (Lond), 2010, 34(10), 1546-1553.
27. An, G.; Lin, T.-N.; Liu, J.-S.; Xue, J.-J.; He, Y.-Y.; Hsu, C.Y. Expression of c-fos and c-jun family genes after focal cerebral ischemia. Ann. Neurol., 1993, 33(5), 457-464.
28. Craig, A.; Meloni, B.; Watt, P.; Knuckey, N. Attenuation of Neuronal Death by Peptide Inhibitors of AP-1 Activation in Acute and Delayed In Vitro Ischaemia (Oxygen/Glucose Deprivation) Models. Intl. J. Peptide Res. Ther., 2011, 17(1), 1-6.
29. Libert, S.; Cohen, D.; Guarente, L. Neurogenesis directed by Sirt1. Nat. Cell Biol., 2008, 10(4), 373-374.
30. Lin, S.J.; Defossez, P.A.; Guarente, L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science, 2000, 289(5487), 2126-2128.
31. Hu, Y.; Liu, J.; Wang, J.; Liu, Q. The controversial links among calorie restriction, SIRT1, and resveratrol. Free Radic. Biol. Med., 2011, 51(2), 250-256.
32. Yun, J.M.; Chien, A.; Jialal, I.; Devaraj, S. Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights. J. Nutr. Biochem., 2011, 23(7), 699-705.
33. Sun, A.Y.; Wang, Q.; Simonyi, A.; Sun, G.Y. Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol. Neurobiol., 2010, 41(2-3), 375-383.
34. Alvira, D.; Yeste-Velasco, M.; Folch, J.; Verdaguer, E.; Canudas, A.M.; Pallas, M.; Camins, A. Comparative analysis of the effects of resveratrol in two apoptotic models: inhibition of complex I and potassium deprivation in cerebellar neurons. Neuroscience, 2007, 147(3), 746-756.
35. Anekonda, T.S. Resveratrol-a boon for treating Alzheimer's disease? Brain Res. Rev., 2006, 52(2), 316-326.
36. Binienda, Z.K.; Beaudoin, M.A.; Gough, B.; Ali, S.F.; Virmani, A. Assessment of 3-nitropropionic acid-evoked peripheral neuropathy in rats: neuroprotective effects of acetyl-l-carnitine and resveratrol. Neurosci. Lett., 2010, 480(2), 117-121.
37. Chang, Y.; Wang, S.J. Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by resveratrol. Neurochem. Int., 2009, 54(2), 135-141.
38. Chao, J.; Yu, M.S.; Ho, Y.S.; Wang, M.; Chang, R.C. Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity. Free Radic. Biol. Med., 2008, 45(7), 1019-1026.
39. Lu, K.T.; Ko, M.C.; Chen, B.Y.; Huang, J.C.; Hsieh, C.W.; Lee, M.C.; Chiou, R.Y.; Wung, B.S.; Peng, C.H.; Yang, Y.L. Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J. Agric. Food Chem., 2008, 56(16), 6910-6913.
40. Nicolini, G.; Rigolio, R.; Scuteri, A.; Miloso, M.; Saccomanno, D.; Cavaletti, G.; Tredici, G. Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochem. Int., 2003, 42(5), 419-429.
41. Sinha, K.; Chaudhary, G.; Gupta, Y.K. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci., 2002, 71(6), 655-665.
42. Vincent, A.M.; Kato, K.; McLean, L.L.; Soules, M.E.; Feldman, E.L. Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms. Antioxid. Redox. Signal., 2009, 11(3), 425-438.
43. Bermudez-Ocana, D.Y.; Ambriz-Tututi, M.; Perez-Severiano, F.; Granados-Soto, V. Pharmacological evidence for the participation of NO-cyclic GMP-PKG-K+ channel pathway in the antiallodynic action of resveratrol. Pharmacol. Biochem. Behav., 2006, 84(3), 535-542.
44. Perez-Severiano, F.; Bermudez-Ocana, D.Y.; Lopez-Sanchez, P.; Rios, C.; Granados-Soto, V. Spinal nerve ligation reduces nitric oxide synthase activity and expression: effect of resveratrol. Pharmacol. Biochem. Behav., 2008, 90(4), 742-747.
45. Pham-Marcou, T.A.; Beloeil, H.; Sun, X.; Gentili, M.; Yaici, D.; Benoit, G.; Benhamou, D.; Mazoit, J.X. Antinociceptive effect of resveratrol in carrageenan-evoked hyperalgesia in rats: prolonged effect related to COX-2 expression impairment. Pain, 2008, 140(2), 274-283.
46. Kim, H.I.; Kim, T.H.; Song, J.H. Resveratrol inhibits Na+ currents in rat dorsal root ganglion neurons. Brain Res., 2005, 1045(1-2), 134-141.
47. Kumar, A.; Kaundal, R.K.; Iyer, S.; Sharma, S.S. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci., 2007, 80(13), 1236-1244.
48. Sharma, S.S.; Kumar, A.; Arora, M.; Kaundal, R.K. Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: focus on functional, sensorimotor and biochemical changes. Free Radic. Res., 2009, 43(4), 400-408.
49. Sharma, S.; Chopra, K.; Kulkarni, S.K. Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha. Phytother. Res., 2007, 21(3), 278-283.
50. Gentilli, M.; Mazoit, J.X.; Bouaziz, H.; Fletcher, D.; Casper, R.F.; Benhamou, D.; Savouret, J.F. Resveratrol decreases hyperalgesia induced by carrageenan in the rat hind paw. Life Sci., 2001, 68(11), 1317-1321.
51. Rochelle, L.G.; Fischer, B.M.; Adler, K.B. Concurrent production of reactive oxygen and nitrogen species by airway epithelial cells in vitro. Free Radic. Biol. Med., 1998, 24(5), 863-868.
52. Yang, Y.B.; Piao, Y.J. Effects of resveratrol on secondary damages after acute spinal cord injury in rats. Acta Pharmacol. Sin., 2003, 24(7), 703-710.
53. Shindo, H.; Tawata, M.; Onaya, T. Reduction of cyclic AMP in the sciatic nerve of rats made diabetic with streptozotocin and the mechanism involved. J. Endocrinol., 1993, 136(3), 431-438.
54. El-Mowafy, A.M.; Alkhalaf, M. Resveratrol activates adenylylcyclase in human breast cancer cells: a novel, estrogen receptorindependent cytostatic mechanism. Carcinogenesis, 2003, 24(5), 869-873.
55. Freshwater, J.D.; Svensson, C.I.; Malmberg, A.B.; Calcutt, N.A. Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats. Diabetes, 2002, 51(7), 2249-2255.
56. Singh, J.N.; Jain, G.; Sharma, S.S. In vitro hyperglycemia enhances sodium currents in dorsal root ganglion neurons: An effect attenuated by carbamazepine. Neuroscience, 2013, 232C, 64-73.
57. Gupta, S.; Kaul, C.L.; Sharma, S.S. Neuroprotective effect of combination of poly (ADP-ribose) polymerase inhibitor and antioxidant in middle cerebral artery occlusion induced focal ischemia in rats. Neurol. Res., 2004, 26(1), 103-107.
58. Leonard, S.S.; Xia, C.; Jiang, B.H.; Stinefelt, B.; Klandorf, H.; Harris, G.K.; Shi, X., Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun., 2003, 309(4), 1017-1026.
59. Wakabayashi, N.; Slocum, S.L.; Skoko, J.J.; Shin, S.; Kensler, T.W. When NRF2 Talks, Who's Listening? Antioxid. Redox. Signal., 2010, 3(1), 17-26.
60. Singh, U.P.; Singh, N.; Singh, B.; Hofseth, L.J.; Price, B.L.; Nagarkatti, M.; Nagarkatti, P. Resveratrol (trans-3, 5, 4'-trihydroxystilbene) induces SIRT1 and down-regulates NF-{kappa}B activation to abrogate DSS-induced colitis. J. Pharmacol. Exp. Ther., 2009, 332(3), 829-839.
61. Liu, C.; Shi, Z.; Fan, L.; Zhang, C.; Wang, K.; Wang, B. Resveratrol improves neuron protection and functional recovery in rat model of spinal cord injury. Brain Res., 2012, 1374, 100-109.
62. Negi, G.; Kumar, A.; Sharma, S.S. Nrf2 and NF-kappaB modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes. Curr. Neurovasc. Res., 2011, 8(4), 294-304.